USANA Health Sciences, Inc. $USNA Shares Acquired by US Bancorp DE

US Bancorp DE lifted its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 13.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,611 shares of the company’s stock after purchasing an additional 535 shares during the period. US Bancorp DE’s holdings in USANA Health Sciences were worth $124,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Exchange Traded Concepts LLC lifted its position in shares of USANA Health Sciences by 7.1% during the first quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company’s stock worth $248,000 after purchasing an additional 606 shares in the last quarter. Versant Capital Management Inc raised its holdings in USANA Health Sciences by 542.5% in the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $31,000 after acquiring an additional 971 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in USANA Health Sciences by 15.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,234 shares of the company’s stock valued at $260,000 after acquiring an additional 985 shares in the last quarter. Parallel Advisors LLC raised its holdings in USANA Health Sciences by 8,141.2% in the first quarter. Parallel Advisors LLC now owns 1,401 shares of the company’s stock valued at $38,000 after acquiring an additional 1,384 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in USANA Health Sciences by 2.7% in the first quarter. Principal Financial Group Inc. now owns 55,076 shares of the company’s stock valued at $1,485,000 after acquiring an additional 1,473 shares in the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a report on Thursday, May 22nd.

Insiders Place Their Bets

In other USANA Health Sciences news, COO Walter Noot sold 6,291 shares of the stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total transaction of $190,554.39. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gilbert A. Fuller sold 1,058 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $29.10, for a total transaction of $30,787.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,364 shares of company stock valued at $342,536. Company insiders own 0.63% of the company’s stock.

USANA Health Sciences Price Performance

USNA opened at $30.39 on Monday. The stock has a market capitalization of $555.23 million, a PE ratio of 16.88, a P/E/G ratio of 0.97 and a beta of 0.61. The firm’s fifty day moving average price is $30.90 and its 200 day moving average price is $29.56. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $41.83.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.20. The firm had revenue of $235.85 million for the quarter, compared to analysts’ expectations of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. On average, equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.